2型糖尿病モデルDKDラットにおけるRTA dh404とダパグリフロジン併用における腎保護効果の検討

Key Word：
Type 2 diabetic model（2型糖尿病モデル）、Dapagliflozin（ダパグリフロジン）、RTAdb404

Kanji Ota^１、Tsuyoshi Kodama^１、Sakuya Ito¹、Yunosuke Yokota¹、Yusuke Kaida¹、Fukami Kei¹、Masami Shinohara^２ 

^１Division of Nephrology, Department of Internal Medicine,Kurume University school of Medicine, Fukuoka, Japan、^２Tokyo Animal & Diet Department, CLEA Japan, Inc., Tokyo, Japan

For more details, please click here (Google Search)

• 第65回 日本腎臓学会学術総会：Kobe International Conference Center in Hyogo, Japan
• June 10-12, 2022

Related CLEA Japan product: SDT fatty/Jcl

For the animal model, please click here ▼

 https://www.clea-japan.com/en/products/diabetes/item_a0150

 https://www.clea-japan.com/products/diabetes/item_a0150

Inquiry（お問い合わせ）

If you have any questions, please feel free to contact us.